DarioHealth (NASDAQ:DRIO) reported quarterly losses of $(0.72) per share which beat the analyst consensus estimate of $(1.22) by 40.98 percent. This is a 82.44 percent increase over losses of $(4.10) per share from the same period last year. The company reported quarterly sales of $5.177 million which missed the analyst consensus estimate of $5.923 million by 12.59 percent. This is a 3.58 percent decrease over sales of $5.369 million the same period last year.